Early home return for patients after prostate adenoma surgery
Evaluation of Early Home Return Care Pathway in Patients Who Have Undergone Endoscopic Enucleation of Prostate Adenoma by Laser
This study is testing a new way to help patients go home sooner after prostate surgery by providing supervised care at home to see if it keeps them safe and helps them recover better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 440 (estimated) |
| Ages | 45 Years and up |
| Sex | Male |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche Academic / other |
| Locations | 1 site (Saint-Jean) |
| Trial ID | NCT05912764 on ClinicalTrials.gov |
What this trial studies
This study evaluates a new rehabilitation care pathway aimed at reducing the hospitalization duration for patients undergoing endoscopic enucleation of prostate adenoma using laser technology. Traditionally, patients are hospitalized for at least 48 hours, but this approach seeks to allow discharge within 24 hours while ensuring patient safety through supervised home care by nurses. The study hypothesizes that this model can be effectively implemented in other healthcare settings without increasing the risk of complications. The intervention focuses on improving patient involvement in their care and enhancing the overall recovery process.
Who should consider this trial
Good fit: Ideal candidates include patients scheduled for endoscopic enucleation of prostate adenoma who have symptomatic benign prostatic hyperplasia and are refractory to medical treatment.
Not a fit: Patients who are bedridden, require continuous anticoagulation, or live outside the care coordination area will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce hospital stays for patients, leading to improved quality of life and reduced healthcare costs.
How similar studies have performed: While this specific approach is novel, similar studies have shown promise in reducing hospitalization times in other surgical contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient planned for endoscopic enucleation of prostate adenoma with laser * Patient with symptomatic benign prostatic hyperplasia and refractory to medical reatment and/or * Patient with benign prostatic hyperplasia complicated by chronic retention of urine and/or * Patient with benign prostatic hyperplasia complicated by prostatitis and/or * Patient with symptomatic benign prostatic hyperplasia Exclusion Criteria: * Patient living beyond the scope of care by the nurses coordination * Bedridden patient or WHO clinical condition \>2 * Patient requiring curative anticoagulation which cannot be interrupted or relayed at home by heparin * Patient with double anti-platelet aggregation who cannot be interrupted
Where this trial is running
Saint-Jean
- Clinique de l'Union — Saint-Jean, France (Recruiting)
Study contacts
- Principal investigator: Philippe ROUVELLAT, MD — Gcs Ramsay Sante
- Study coordinator: Philippe ROUVELLAT, MD
- Email: r.rouvellat.union@gmail.com
- Phone: + 33 5 61 37 82 93
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.